NCT03146273

Brief Summary

This clinical study is designed to evaluate difference in the AUC of the absorption of Multivitamin and minerals defined in the protocol

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2017

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 6, 2017

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 9, 2017

Completed
Same day until next milestone

Study Start

First participant enrolled

May 9, 2017

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 10, 2017

Completed
21 days until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2017

Completed
Last Updated

September 26, 2024

Status Verified

September 1, 2024

Enrollment Period

1 month

First QC Date

May 6, 2017

Last Update Submit

September 24, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Mean fractional absorption

    A comparison of mean fractional absorption of the two Multivitamin mineral formulations (gel vs. tablet/capsule).

    6 hours

Secondary Outcomes (1)

  • Absorption rate

    6 hours

Study Arms (2)

Tablet

ACTIVE COMPARATOR

The tablet/capsule will be administered as a single dose of Multivitamins in tablet after 12 hours of fasting. The participants will be monitored during 6 hours for the level of minerals and Multivitamin minerals in the blood, adverse events and vital signs. The results will be used for the AUC calculation of the absorption in order to compare with the Gel administration absorption.

Dietary Supplement: Multivitamins

Gel

ACTIVE COMPARATOR

The gel will be administrated to the same group of patients in the single dose of Multivitamins in gel after 12 hours of fasting. The participants will be monitored during 6 hours for the level of minerals and Multivitamin minerals in the blood, adverse events and vital signs. The results will be used for the AUC calculation of the absorption in order to compare with the Tablet administration absorption.

Dietary Supplement: Multivitamins

Interventions

MultivitaminsDIETARY_SUPPLEMENT

After the study product administration blood tests will be performed in order to calculate the AUC for each mineral and vitamin - Vit A Vit E Folic Acid Vit C Calcium Magnesium After the washout period, the same procedure will be done for the additional formulation of the multivitamins.

GelTablet

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Healthy male or female and aged 18-65 years
  • BMI - 19-24
  • Subject is not pregnant and is not nursing
  • Signed Informed Consent Form

You may not qualify if:

  • Current use of multivitamin or mineral complexes (washout of 4 days before Visit 2 is permitted)
  • Participants with known vitamins or mineral deficiencies
  • Diabetes Type II
  • Smoking
  • Subjects who have undergone surgery within the last 3 months.
  • Subjects with a clinically significant (during last 3 months) infectious, immune-mediated or active malignant disease.
  • Subjects who are receiving an elemental diet or parenteral nutrition.
  • Subjects who are treated with insulin.
  • Women with childbearing potential unless surgically sterile or using adequate contraception (either IUD, oral or Depo-provera contraceptive, or barrier plus spermicide); pregnant or breastfeeding mothers.
  • Subjects who will be unavailable for the duration of the trial, who are unlikely to be compliant with the protocol, or who are felt to be unsuitable by the Investigator for any other reason.
  • Known sensitivity to any ingredients in the study product
  • History of addiction or drug abuse
  • Alcoholic regular use

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Israel

Tel Aviv, Central District, Israel

Location

MeSH Terms

Conditions

Avitaminosis

Interventions

Geritol

Condition Hierarchy (Ancestors)

Deficiency DiseasesMalnutritionNutrition DisordersNutritional and Metabolic Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
PREVENTION
Intervention Model
CROSSOVER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 6, 2017

First Posted

May 9, 2017

Study Start

May 9, 2017

Primary Completion

June 10, 2017

Study Completion

July 1, 2017

Last Updated

September 26, 2024

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will not share

The study results will be published.

Locations